| 156.06 Delayed Data As of Dec 18 |  +1.04 / +0.67%Today’s Change | 110.68 Today|||52-Week Range 175.00 | +38.46% Year-to-Date |
| Will Walgreens (WBA) Q1 Earnings Gain From Overall Strength? Dec 18 / Zacks.com - Paid Partner Content | Edwards Lifesciences Advances in AI With Bay Labs Tie-Up Dec 13 / Zacks.com - Paid Partner Content |
| Previous close | 155.02 |
| Today’s open | 158.19 |
| Day’s range | 154.51 - 158.23 |
| Volume | 1,083,334 |
| Average volume (3 months) | 1,584,083 |
| Market cap | $31.0B |
| Earnings growth (last year) | +3.75% |
| Earnings growth (this year) | +23.64% |
| Earnings growth (next 5 years) | +17.80% |
| Revenue growth (last year) | +15.91% |
| P/E ratio | 46.9 |
| Price/Sales | 7.08 |
| Price/Book | 10.51 |
| Today’s change | Today’s % change | |
|---|---|---|
| SNNSmith & Nephew PLC | -0.65 | -1.75% |
| STESTERIS plc | -1.47 | -1.33% |
| HRCHill-Rom Holdings In... | +0.68 | +0.76% |
| ISRGIntuitive Surgical | +0.61 | +0.13% |
| Next reporting date | February 11, 2019 |
| EPS forecast (this quarter) | $1.17 |
| Annual revenue (last year) | $3.4B |
| Annual profit (last year) | $583.6M |
| Net profit margin | 16.99% |
Sector Health Technology |
Industry Medical Specialties |
Chairman & Chief Executive Officer Michael A. Mussallem |
Chief Financial Officer & Vice President Scott B. Ullem |
Corporate headquarters Irvine, California |
